验证数据展示
经过测试的应用
Positive IF-P detected in | human colon tissue |
Positive IF/ICC detected in | HT-29 cells, human colon cancer tissue |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL555-60183 targets Cytokeratin 20 in IF/ICC, IF-P applications and shows reactivity with human samples.
经测试应用 | IF/ICC, IF-P Application Description |
经测试反应性 | human |
免疫原 | Cytokeratin 20 fusion protein Ag11336 种属同源性预测 |
宿主/亚型 | Mouse / IgG2b |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | keratin 20 |
别名 | KRT20, keratin 20, K20, Cytokeratin-20, CK-20 |
计算分子量 | 424 aa, 48 kDa |
观测分子量 | 46 kDa |
GenBank蛋白编号 | BC031559 |
基因名称 | Cytokeratin 20 |
Gene ID (NCBI) | 54474 |
RRID | AB_2923893 |
偶联类型 | CoraLite®555 Fluorescent Dye |
最大激发/发射波长 | 557 nm / 570 nm |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | P35900 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells. Keratin expression is highly regulated, tissue specific, and varies according to cell-state. Type I keratins consist of acidic, low molecular weight proteins with MW ranging from 40 kDa (KRT19) to 64 kDa (KRT9). Type 2 keratins consist of basic or neutral, high molecular weight proteins with MW from 52 kDa (KRT8) to 67 kDa (KRT18).Keratin 20 is a type I cytokeratin. It is a major cellular protein of mature enterocytes and goblet cells and is specifically found in the gastric and intestinal mucosa.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL555 Cytokeratin 20 antibody CL555-60183 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |